by Truveta Staff | Nov 1, 2023 | News
October was a whirlwind month for Truveta, marked by participation in various conferences across the United States. In the span of less than 10 days, Truveta experts and customers presented at four different events, showcasing how Truveta Data is being used to enable...
by Terry Myerson, CEO | Aug 1, 2023 | Culture
It is so helpful to have a world view of the industry you participate in, a view that is long term coherent, and toward which everything eventually converges to. Over the course of my tech career, I came to appreciate a complex world view balancing the intersecting...
by Truveta Staff | May 25, 2023 | Technology
Every 40 seconds, someone in the United States has a stroke. Every 3 minutes and 14 seconds, someone dies from a stroke. The fifth leading cause of death in the US and a leading cause of adult disability, 7.8 million adults have experienced a stroke in their lifetime....
by Truveta Staff | May 17, 2023 | News
We are excited to announce the expansion of the Truveta community to include new life science partners, including Reprieve Cardiovascular and SK Life Science, joining previously announced pioneers Pfizer, Boston Scientific Corporation, and Alpine Immune Sciences. We...
by Truveta Staff | May 5, 2023 | Technology
Medical device companies face a unique challenge when they want to study their product performance post-launch – a significant lack of detailed data on use of their device in clinical practice and the related outcomes. Understanding clinical outcomes or adverse events...
